| Prokaryotic hopanoids: the biosynthesis of the bacteriohopane skeleton: Formation of isoprenic units from two distinct acetate pools and a novel type of carbon/carbon linkage … G Flesch, M Rohmer European Journal of Biochemistry 175 (2), 405-411, 1988 | 320 | 1988 |
| Oxcarbazepine placebo-controlled, dose-ranging trial in refractory partial epilepsy. G Barcs, EB Walker, CE Elger, A Scaramelli, H Stefan, Y Sturm, A Moore, ... Epilepsia 41 (12), 1597-1607, 2000 | 293 | 2000 |
| Absolute bioavailability and pharmacokinetics of valsartan, an angiotensin II receptor antagonist, in man G Flesch, PH Müller, P Lloyd European journal of clinical pharmacology 52, 115-120, 1997 | 281 | 1997 |
| Clinical pharmacology and pharmacokinetics of oxcarbazepine P Lloyd, G Flesch, W Dieterle Epilepsia 35, S10-S13, 1994 | 191 | 1994 |
| Pharmacokinetics, disposition and biotransformation of [14C]-radiolabelled valsartan in healthy male volunteers after a single oral dose F Waldmeier, G Flesch, P Mu Ller, T Winkler, HP Kriemler, P Buhlmayer, ... Xenobiotica 27 (1), 59-71, 1997 | 190 | 1997 |
| Overview of the clinical pharmacokinetics of oxcarbazepine G Flesch Clinical drug investigation 24, 185-203, 2004 | 160 | 2004 |
| Pharmacokinetics of valsartan in patients with liver disease LJ Brookman, PE Rolan, IS Benjamin, KR Palmer, PJ Wyld, P Lloyd, ... Clinical pharmacology & therapeutics 62 (3), 272-278, 1997 | 120 | 1997 |
| Pharmacokinetics and pharmacodynamic effects of the angiotensin II antagonist valsartan at steady state in healthy, normotensive subjects P Müller, G Flesch, M De Gasparo, M Gasparini, H Howald European journal of clinical pharmacology 52, 441-449, 1997 | 98 | 1997 |
| Pharmacokinetics of pamidronate in patients with bone metastases S Leyvraz, U Hess, G Flesch, J Bauer, S Hauffe, JM Ford, P Burckhardt JNCI: Journal of the National Cancer Institute 84 (10), 788-792, 1992 | 79 | 1992 |
| Determination of the bisphosphonate pamidronate disodium in urine by pre-column derivatization with fluorescamine, high-performance liquid chromatography and fluorescence detection G Flesch, SA Hauffe Journal of Chromatography B: Biomedical Sciences and Applications 489 (2 …, 1989 | 72 | 1989 |
| Prokaryotic triterpenoids. A novel hopanoid from the ethanol-producing bacterium Zymomonas mobilis. G Flesch, M Rohmer Biochemical Journal 262 (2), 673, 1989 | 71 | 1989 |
| An interaction study with cimetidine and the new angiotensin II antagonist valsartan EK Schmidt, KH Antonin, G Flesch, A Racine-Poon European journal of clinical pharmacology 53, 451-458, 1998 | 57 | 1998 |
| Determination of the R-(−) and S-(+) enantiomers of the monohydroxylated metabolite of oxcarbazepine in human plasma by enantioselective high-performance liquid chromatography G Flesch, E Francotte, F Hell, PH Degen Journal of Chromatography B: Biomedical Sciences and Applications 581 (1 …, 1992 | 57 | 1992 |
| Intravenous pamidronate for treatment of reflex sympathetic dystrophy during breast feeding K Siminoski, AA Fitzgerald, G Flesch, MS Gross Journal of Bone and Mineral Research 15 (10), 2052-2055, 2000 | 53 | 2000 |
| Pharmacokinetic evaluation of pamidronate after oral administration: a study on dose proportionality, absolute bioavailability, and effect of repeated administration L Hyldstrup, G Flesch, SA Hauffe Calcified tissue international 53, 297-300, 1993 | 52 | 1993 |
| The influence of food on the disposition of the antiepileptic oxcarbazepine and its major metabolites in healthy volunteers PH Degen, G Flesch, JM Cardot, C Czendlik, W Dieterle Biopharmaceutics & drug disposition 15 (6), 519-526, 1994 | 51 | 1994 |
| Improved determination of the bisphosphonate pamidronate disodium in plasma and urine by pre-column derivatization with fluorescamine, high-performance liquid chromatography … G Flesch, N Tominaga, P Degen Journal of Chromatography B: Biomedical Sciences and Applications 568 (1 …, 1991 | 49 | 1991 |
| Pharmacokinetics of the monohydroxy derivative of oxcarbazepine and its enantiomers after a single intravenous dose given as racemate compared with a single oral dose of … G Flesch, C Czendlik, D Renard, P Lloyd Drug metabolism and disposition 39 (6), 1103-1110, 2011 | 43 | 2011 |
| Effects of dextropropoxyphene on the steady‐state kinetics of oxcarbazepine and its metabolites PH Mogensen, L Jorgensen, J Boas, M Dam, A Vesterager, G Flesch, ... Acta neurologica scandinavica 85 (1), 14-17, 1992 | 40 | 1992 |
| Pharmacokinetic and pharmacodynamic interaction of single oral doses of valsartan and furosemide M Bindschedler, P Degen, G Flesch, M De Gasparo, G Preiswerk European journal of clinical pharmacology 52, 371-378, 1997 | 35 | 1997 |
